Financial Ratios

DR. LAL PATHLABS LTD.

NSE : LALPATHLABBSE : 539524ISIN CODE : INE600L01024Industry : Hospital & Healthcare ServicesHouse : Arvind Lal
BSE2262.65-6.25 (-0.28 %)
PREV CLOSE ( ) 2268.90
OPEN PRICE ( ) 2279.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4543
TODAY'S LOW / HIGH ( )2252.80 2306.00
52 WK LOW / HIGH ( )1790.1 2766.85
NSE2262.85-11.9 (-0.52 %)
PREV CLOSE( ) 2274.75
OPEN PRICE ( ) 2261.05
BID PRICE (QTY) 2262.85 (23)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 522528
TODAY'S LOW / HIGH( ) 2253.25 2308.00
52 WK LOW / HIGH ( )1791.05 2767.1
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)35.0741.4233.6126.7823.45
   CEPS(Rs)44.9250.5441.9834.9427.79
   DPS(Rs)12.0012.0020.0012.006.00
   Book NAV/Share(Rs)195.74169.74141.25117.99108.32
   Tax Rate(%)25.2025.1125.1126.2833.15
Margin Ratios
   Core EBITDA Margin(%)26.0427.2827.3325.7424.28
   EBIT Margin(%)24.0426.0626.0924.9225.16
   Pre Tax Margin(%)22.0924.5425.0923.7725.10
   PAT Margin (%)16.5318.3818.7917.5216.78
   Cash Profit Margin (%)21.1722.4223.4722.8619.88
Performance Ratios
   ROA(%)13.0918.5319.7119.0720.31
   ROE(%)19.1926.6425.9323.6623.53
   ROCE(%)22.7132.2734.8232.6034.34
   Asset Turnover(x)0.791.011.051.091.21
   Sales/Fixed Asset(x)2.523.173.083.584.77
   Working Capital/Sales(x)4.687.571.781.961.76
Efficiency Ratios
   Fixed Capital/Sales(x)0.400.320.330.280.21
   Receivable days13.4512.6813.9314.8114.61
   Inventory Days6.527.6511.5011.878.53
   Payable days123.48105.61121.20120.8299.92
Valuation Parameters
   PER(x)52.1262.9480.5652.3344.97
   PCE(x)40.7051.5964.4940.1137.94
   Price/Book(x)9.3415.3619.1711.889.73
   Yield(%)0.660.460.740.860.57
   EV/Net Sales(x)8.4511.4614.548.747.13
   EV/Core EBITDA(x)29.4538.0747.2628.8825.24
   EV/EBIT(x)35.1443.9855.7435.0728.35
   EV/CE(x)6.539.8714.028.597.95
   M Cap / Sales8.6111.5715.149.177.54
Growth Ratio
   Net Sales Growth(%)-5.8426.0517.039.3313.75
   Core EBITDA Growth(%)-10.3023.3119.0017.0514.49
   EBIT Growth(%)-13.1625.9122.518.2914.24
   PAT Growth(%)-15.3223.2625.5114.1916.15
   EPS Growth(%)-15.3423.2625.5114.1916.13
Financial Stability Ratios
   Total Debt/Equity(x)0.150.240.000.000.00
   Current Ratio(x)1.871.554.324.085.92
   Quick Ratio(x)1.821.464.163.825.71
   Interest Cover(x)12.3717.1026.2321.65394.50
   Total Debt/Mcap(x)0.020.020.000.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.